Wednesday, Aug 15th

Last update:10:30:34 AM GMT

Load a sample iFrame " href="/gujarati/others/vedio-gujarati">Video-Gujarati

Generics Deal Cuts Cost of AIDS Drugs Further

Print PDF

A woman who is infected with HIV prepares her medicines in a shelter house
The cost of AIDS medicines in poor countries is to come down further, following a new bulk purchase arrangement negotiated with a group of generic drug manufacturers.

The Clinton Foundation HIV/AIDS Initiative and the international drug–purchasing consortium Unitaid said Friday they had struck deals offering steeper discounts on a range of life–saving treatments.

The price of most affordable generic second–line drug regimen–needed when patients develop resistance to initial treatment–falls to $590 annually, from more than $700 a year ago.

And a one–pill, once–daily first–line regimen based on the drug tenofovir is now available for $210 annually, down 30 percent from 2008.

In total, new price agreements have been struck for 41 adult and paediatric formulations at an average reduction of 16 percent compared to 2008.

There is no cure for the human immunodeficiency virus (HIV) that causes AIDS, but combinations of drugs can keep the virus from replicating and damaging the immune system.

An estimated 33 million people globally are infected with the AIDS virus, most of them living in Africa and other developing countries.

Disclaimer: The news story on this page is the copyright of the cited publication. This has been reproduced here for visitors to review, comment on and discuss. This is in keeping with the principle of ‘Fair dealing‘ or ‘Fair use’. Visitors may click on the publication name, in the news story, to visit the original article as it appears on the publication’s website.

Source: Reuters


આ આપની સાઈટ છે, સુચના અથવા પ્રતિક્રીયા આવકાર્ય છે. જણાવશો, તો અમો તેના આધારે ઉત્તમ કરવાના પ્રયત્‍નો કરશું.

સુચના જણાવો



Link to Aarogya



Know Your Rights!

અમારીસાથી આઓ